Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 1 day agoBut Sanofi is one of the world's largest vaccine makers and has a robust flu portfolio that...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 2 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven by the company’s...
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WHTC 1450 Holland· 5 days ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 days agoThe licensing agreement will allow Novavax to lift its "going concern" warning, which it first...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine ...
WKRN Nashville· 2 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive...SNY). The ...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 1 day agoNovavax stock more than doubled after the announcement. It puts Novavax on solid footing, after...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 1 day agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 1 day agoCash and Cash Equivalents: Ended the quarter with $480.59 million...568.51 million at the end of the previous quarter. On May 10, 2024, Novavax Inc (NASDAQ ...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...